TABERNACL: Temporary Hemodynamic Stabilization In Vivo.
Rim N HalabyChristopher G BruceDogangun UzunToby RogersJaffar M KhanAndi E JaimesLaurie P GrantVasilis C BabaliarosAdam B GreenbaumRobert J LedermanPublished in: Circulation. Cardiovascular interventions (2024)
TABERNACL improves hemodynamics and reduces coronary ischemia by electrocardiography in animals with acute severe aortic regurgitation. TABERNACL valves obstruct the diastolic regurgitant orifice without systolic obstruction. This may prove a lifesaving bridge to definitive valve replacement therapy.
Keyphrases
- replacement therapy
- aortic valve
- aortic stenosis
- left ventricular
- aortic valve replacement
- blood pressure
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- liver failure
- smoking cessation
- drug induced
- respiratory failure
- heart failure
- aortic dissection
- coronary artery
- coronary artery disease
- mitral valve
- early onset
- ejection fraction
- locally advanced
- hepatitis b virus
- squamous cell carcinoma
- radiation therapy
- atrial fibrillation